ACHE and Sepsis: A novel anti-inflammatory idea based on targeting forebrain cholinergic signaling in sepsis and other diseases is characterized by immune dysregulation, suggesting a promising clinical application of anti-acetylcholinesterase inhibitors in inflammatory conditions (34, 35).